Naveen N. Anand
Plus aucun poste en cours
Profil
Naveen N.
Anand joined Idera Pharmaceuticals, Inc. in December 2004 as Vice President of Corporate and Business Development.
Previously, he was a Consultant of Idera Pharmaceuticals from September 2004 to December 2004.
From 2002 to 2004, he was Vice President of Business Development for Shire Biologics.
Dr. Anand was Vice President- Business Development and Licensing for Procyon Biopharma from 1999 to 2002.
He was Manager-New Products and New Markets Development for Aventis Pasteur from 1991 to 1999.
Dr. Anand received a BS degree and a Masters degree in Pharmaceutical Sciences from Panjab University, a PhD degree from the University of Cambridge and an MBA from the University of Toronto.
Anciens postes connus de Naveen N. Anand
| Sociétés | Poste | Fin |
|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
Formation de Naveen N. Anand
| University of Cambridge | Doctorate Degree |
| University of Toronto | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |